Abstract
Isatin and its derivatives have been widely studied due to their biological activities. Recently there has been a renewed interest in the synthesis of new derivatives by use of organocatalysts. This review deals with this area.
Keywords: Aldol, Asymmetric Catalysis, Friedel-Crafts, Henry, Isatin, Morita-Baylis-Hillman, Organocatalysis.
Current Organic Chemistry
Title:Enantioselective Organocatalytic Reactions with Isatin
Volume: 17 Issue: 18
Author(s): MariFe Flores, Javier Pena, Pilar García-García, Narciso M. Garrido and David Diez
Affiliation:
Keywords: Aldol, Asymmetric Catalysis, Friedel-Crafts, Henry, Isatin, Morita-Baylis-Hillman, Organocatalysis.
Abstract: Isatin and its derivatives have been widely studied due to their biological activities. Recently there has been a renewed interest in the synthesis of new derivatives by use of organocatalysts. This review deals with this area.
Export Options
About this article
Cite this article as:
Flores MariFe, Pena Javier, García-García Pilar, Garrido M. Narciso and Diez David, Enantioselective Organocatalytic Reactions with Isatin, Current Organic Chemistry 2013; 17 (18) . https://dx.doi.org/10.2174/13852728113179990092
DOI https://dx.doi.org/10.2174/13852728113179990092 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting STAT1 in Both Cancer and Insulin Resistance Diseases
Current Protein & Peptide Science Pharmaceutical Production of Anti-tumor and Immune-potentiating Enterococcus faecalis-2001 β-glucans: Enhanced Activity of Macrophage and Lymphocytes in Tumor-implanted Mice
Current Pharmaceutical Biotechnology Cyanidin 3-O-Glucoside Induces the Apoptosis in the Osteosarcoma Cells through Upregulation of the PPARγ and P21: An <i>In Vitro</i> Study
Anti-Cancer Agents in Medicinal Chemistry Cancer Resistance to Type II Topoisomerase Inhibitors
Current Medicinal Chemistry Optical and Multimodal Peptide-Based Probes for In Vivo Molecular Imaging
Anti-Cancer Agents in Medicinal Chemistry Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets
Current Genomics Lectin-Carbohydrate Interactions: Implications for the Development of New Anticancer Agents
Current Medicinal Chemistry New Biomarkers for Colon Cancer Diagnosis: A Review of Recent Patents
Recent Patents on Biomarkers ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design The Complex Airway in Childhood Asthma
Current Pediatric Reviews The Development of Oncolytic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer
Current Cancer Drug Targets Molecular and Biological Aspects of the Bovine Immunodeficiency Virus
Current HIV Research Thalidomide Analogues as Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Synthesis of Nitroaromatic Compounds as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Growth and Trophic Factors, pH and the Na+/H+ Exchanger in Alzheimers Disease, Other Neurodegenerative Diseases and Cancer: New Therapeutic Possibilities and Potential Dangers
Current Alzheimer Research Combination of Hypoxia and RNA-Interference Targeting VEGF Induces Apoptosis in Hepatoma Cells Via Autocrine Mechanisms
Current Pharmaceutical Biotechnology Target-oriented Mechanisms of Novel Herbal Therapeutics in the Chemotherapy of Gastrointestinal Cancer and Inflammation
Current Pharmaceutical Design Imaging of Tumor Angiogenesis: Current Approaches and Future Prospects
Current Pharmaceutical Design Gene Therapy for Chronic Granulomatous Disease: Current Status and Future Perspectives
Current Gene Therapy Small Molecules in Cancer Therapy: Cytotoxics and Molecularly Targeted Agents
Current Signal Transduction Therapy